COVID-19 and hydroxychloroquine

May 17, 2020

https://www.ncbi.nlm.nih.gov/pubmed/32402766

2020 Apr 27;142:109783. doi: 10.1016/j.mehy.2020.109783. [Epub ahead of print]

Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.

 

 

Comments are closed.

Leabright's Blog

Just another WordPress.com weblog

WordPress.com

WordPress.com is the best place for your personal blog or business site.

%d bloggers like this: